$3.50
0.154.32%
Last update: May 15, 12:14 PM
Cytek Biosciences Inc Earnings Estimates
CTKBNASDAQ
Cytek Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:CTKB
Cytek Biosciences (CTKB) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $-0.02 and quarterly revenue of $48.57M.
In the most recent quarter (Q1), Cytek Biosciences reported EPS of $-0.15, missing estimates of $-0.09 by 0.67%. Revenue came in at $44.13M, missing the estimate of $44.22M by 1.00%.
Cytek Biosciences has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Cytek Biosciences has averaged an EPS surprise of 9.17% and a revenue surprise of 0.28%.
Earnings Date
Aug 5
EPS Estimate
$-0.020
Quarterly Revenue Estimate
$48.57M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$204.17M
Cytek Biosciences Earnings History
Analyze the earnings history of Cytek Biosciences using advanced sorting and filters.
Loading calendar...
Cytek Biosciences (CTKB) Earnings Per Share
The chart below shows Cytek Biosciences's reported EPS compared to analyst estimates over recent quarters.
Cytek Biosciences (CTKB) Revenue
The chart below shows Cytek Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Cytek Biosciences (NASDAQ:CTKB) reporting earnings?
Cytek Biosciences (CTKB) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Cytek Biosciences (NASDAQ:CTKB)?
The Actual EPS was $-0.15, which missed the estimate of $-0.09.
What were Cytek Biosciences’s (NASDAQ:CTKB) revenues?
The Actual Revenue was $44.13M, which missed the estimate of $44.22M.
